Skip to content

SYNERGY PHARMACEUTICALS, INC.

CIK 0001347613

Revenue (TTM)
Q3 Nov 2018
Net Income (TTM)
Q3 Nov 2018
EPS Diluted (TTM)
Q3 Nov 2018
Gross Margin
Q3 Nov 2018
Operating Margin
Q3 Nov 2018
Net Margin
Q3 Nov 2018
Free Cash Flow (TTM)
−$114.98M
Q3 Nov 2018
Cash
$45.65M
Q3 Nov 2018
Total Debt
$100.33M
Q3 Nov 2018
Shares Outstanding
248.04M sh
Q3 Nov 2018

Cash Flow

Balance Sheet

Cash vs Debt

Recent filings